eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | cardiogenic shock |
| Comorbidity | C0027051|myocardial infarction (mi) |
| Sentences | 6 |
| PubMedID- 21130711 | Although the use of percutaneous circulatory assist devices is gaining increasing acceptance as an adjunct to percutaneous coronary intervention (pci) in patients with cardiogenic shock, their role in patients with acute myocardial infarction (mi) without hemodynamic compromise and elective high-risk pci remains controversial. |
| PubMedID- 24848410 | Recent findings: recently published randomized controlled trials (rcts) and meta-analyses have demonstrated acceptable safety for iabp but have raised doubt over efficacy in acute myocardial infarction (mi) both with and without cardiogenic shock. |
| PubMedID- 23508129 | Background and objectives: the benefit of early statin treatment following acute myocardial infarction (mi) complicated with cardiogenic shock (cs) has not been well studied. |
| PubMedID- 22013292 | [13] the various indications are acute myocardial infarction (mi) with cardiogenic shock, post-coronary artery bypass graft (high-risk cases with low ejection fraction of <20%), acute mitral insufficiency, and cardiac transplantation. |
| PubMedID- 23940425 | Background: the clinical outcome of patients with myocardial infarction (mi) complicated by cardiogenic shock (cs) who require mechanical ventilation (mv) is poor. |
| PubMedID- 23453102 | Background: although radial approach is increasingly used in percutaneous coronary interventions (pcis) including in acute myocardial infarction (mi), patients with cardiogenic shock have been excluded from comparisons with femoral approach. |
Page: 1